File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis

TitleAntiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis
Authors
Issue Date2014
PublisherJohn Wiley & Sons, Ltd.
Citation
Cochrane Database of Systematic Reviews: Reviews, 2014 How to Cite?
AbstractBACKGROUND: Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT seizures is controversial, and there is currently no consensus on the optimal management of post-ICVT seizures. This is an updated version of the original Cochrane review published in The Cochrane Library 2006, Issue 3. OBJECTIVES: To assess the effects of AEDs for the primary and secondary prevention of seizures related to ICVT.(1) For the question of primary prevention, we aimed to examine whether AEDs reduce the likelihood of seizures in people who have had an ICVT but have not had a seizure.(2) For the question of secondary prevention, we aimed to examine whether AEDs reduce the likelihood of further seizures in people who have had an ICVT and at least one seizure. SEARCH METHODS: We aimed to identify relevant studies in the Cochrane Epilepsy Group and Cochrane Stroke Group Specialised Registers. We also undertook specialised searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2013, Issue 7) and MEDLINE (Ovid 1946 to 22 August 2013) and checked the reference lists of articles retrieved from the searches. SELECTION CRITERIA: We considered all randomised and quasi-randomised controlled trials in which participants were assigned to a treatment group (that is, receiving at least one AED) or control group (receiving placebo or no drug). DATA COLLECTION AND ANALYSIS: Both review authors independently screened and assessed the methodological quality of the studies. If studies had been included in the review, then one review author would have extracted the data and the other would have checked the extracted data. MAIN RESULTS: No relevant studies were found. AUTHORS' CONCLUSIONS: There is no evidence to support or refute the use of antiepileptic drugs for the primary or secondary prevention of seizures related to intracranial venous thrombosis. Well-designed randomised controlled trials are urgently needed to inform practice. Since the last version of this review no new studies have been found.
Persistent Identifierhttp://hdl.handle.net/10722/203121

 

DC FieldValueLanguage
dc.contributor.authorPrice, Men_US
dc.contributor.authorGünther, Aen_US
dc.contributor.authorKwan, SKJen_US
dc.date.accessioned2014-09-19T11:31:47Z-
dc.date.available2014-09-19T11:31:47Z-
dc.date.issued2014en_US
dc.identifier.citationCochrane Database of Systematic Reviews: Reviews, 2014en_US
dc.identifier.urihttp://hdl.handle.net/10722/203121-
dc.description.abstractBACKGROUND: Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT seizures is controversial, and there is currently no consensus on the optimal management of post-ICVT seizures. This is an updated version of the original Cochrane review published in The Cochrane Library 2006, Issue 3. OBJECTIVES: To assess the effects of AEDs for the primary and secondary prevention of seizures related to ICVT.(1) For the question of primary prevention, we aimed to examine whether AEDs reduce the likelihood of seizures in people who have had an ICVT but have not had a seizure.(2) For the question of secondary prevention, we aimed to examine whether AEDs reduce the likelihood of further seizures in people who have had an ICVT and at least one seizure. SEARCH METHODS: We aimed to identify relevant studies in the Cochrane Epilepsy Group and Cochrane Stroke Group Specialised Registers. We also undertook specialised searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2013, Issue 7) and MEDLINE (Ovid 1946 to 22 August 2013) and checked the reference lists of articles retrieved from the searches. SELECTION CRITERIA: We considered all randomised and quasi-randomised controlled trials in which participants were assigned to a treatment group (that is, receiving at least one AED) or control group (receiving placebo or no drug). DATA COLLECTION AND ANALYSIS: Both review authors independently screened and assessed the methodological quality of the studies. If studies had been included in the review, then one review author would have extracted the data and the other would have checked the extracted data. MAIN RESULTS: No relevant studies were found. AUTHORS' CONCLUSIONS: There is no evidence to support or refute the use of antiepileptic drugs for the primary or secondary prevention of seizures related to intracranial venous thrombosis. Well-designed randomised controlled trials are urgently needed to inform practice. Since the last version of this review no new studies have been found.en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Ltd.en_US
dc.relation.ispartofCochrane Database of Systematic Reviews: Reviewsen_US
dc.titleAntiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosisen_US
dc.typeArticleen_US
dc.identifier.emailKwan, SKJ: jskkwan@hku.hken_US
dc.identifier.authorityKwan, SKJ=rp01868en_US
dc.identifier.doi10.1002/14651858.CD005501.pub3en_US
dc.identifier.hkuros238968en_US
dc.publisher.placeChichester, UKen_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats